Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

The privately-held, Richmond, Virginia-based kaléo Pharma (formerly Intelliject) today received FDA approval for Evzio®, an automatic injector of the opioid overdose antidote, naloxone, specifically ...

Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. FDA has accepted Eisai's Biologics License Application for lecanemab-irmb, marketed as LEQEMBI, which is designed for subcutaneous ...

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged ...

Diabetes drugmaker Xeris Pharmaceuticals made a $75 million bet last summer when it went public to back an FDA submission for its shelf-stable glucagon injector pen. Now, more than a year later, Xeris ...

Kaléo announced that Auvi-Q (epinephrine injection) Auto-injector will be available in pharmacies beginning February 14th. Kaléo announced that Auvi-Q (epinephrine injection) Auto-injector will be ...

Auvi-Q 0.1mg is the first epinephrine auto-injector specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 ...

Lindsay Green learned that her 2-year-old son, Everett, had a peanut allergy when he was around 10 months old, leading her to learn more about how to protect her baby. Now, she has taken this concern ...

For additional information about Adrenaclick® including prescribing information, please visit the website at: www.adrenaclick.com. Epinephrine auto-injector is an emergency injection (“shot”) of ...

WALTHAM, Mass., June 26, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) accepted the supplemental new drug ...

The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, heightened demand for self-administration therapeutics, and intensifying focus ...

The latest version of Instron’s Autoinjector Testing System was developed in close collaboration with CDMOs and pharmaceutical device manufacturers. It can perform thorough functioning testing on ...